Modulation of tumor-associated macrophage activity with radiation therapy: a systematic review

• Published in: Strahlentherapie und Onkologie Vol. 199; no. 12; pp. 1173 - 1190
• Main Authors: Becherini, Carlotta, Lancia, Andrea, Detti, Beatrice, Lucidi, Sara, Scartoni, Daniele, Ingrosso, Gianluca, Carnevale, Maria Grazia, Roghi, Manuele, Bertini, Niccolò, Orsatti, Carolina, Mangoni, Monica, Francolini, Giulio, Marani, Simona, Giacomelli, Irene, Loi, Mauro, Pergolizzi, Stefano, Bonzano, Elisabetta, Aristei, Cynthia, Livi, Lorenzo
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.12.2023; Springer Nature B.V
• Subjects: Anticancer properties; Cancer therapies; Immune system; Macrophages; Medicine; Medicine & Public Health; Oncology; Qualitative analysis; Radiation dosage; Radiation therapy; Radiotherapy; Review Article; Systematic review; Radiobiology; Radiotherapy; Macrophages; Immunomodulation; Cancer
• ISSN: 0179-7158; 1439-099X
• DOI: 10.1007/s00066-023-02097-3

Objective Tumor-associated macrophages (TAMs) are the most represented cells of the immune system in the tumor microenvironment (TME). Besides its effects on cancer cells, radiation therapy (RT) can alter TME composition. With this systematic review, we provide a better understanding on how RT can regulate macrophage characterization, namely the M1 antitumor and the M2 protumor polarization, with the aim of describing new effective RT models and exploration of the possibility of integrating radiation with other available therapies. Methods A systematic search in line with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines was carried out in PubMed, Google Scholar, and Scopus. Articles from January 2000 to April 2020 which focus on the role of M1 and M2 macrophages in the response to RT were identified. Results Of the 304 selected articles, 29 qualitative summary papers were included in our analysis (16 focusing on administration of RT and concomitant systemic molecules, and 13 reporting on RT alone). Based on dose intensity, irradiation was classified into low (low-dose irradiation, LDI; corresponding to less than 1 Gy), moderate (moderate-dose irradiation, MDI; between 1 and 10 Gy), and high (high-dose irradiation, HDI; greater than 10 Gy). While HDI seems to be responsible for induced angiogenesis and accelerated tumor growth through early M2-polarized TAM infiltration, MDI stimulates phagocytosis and local LDI may represent a valid treatment option for possible combination with cancer immunotherapeutic agents. Conclusion TAMs seem to have an ambivalent role on the efficacy of cancer treatment. Radiation therapy, which exerts its main antitumor activity via cell killing, can in turn interfere with TAM characterization through different modalities. The plasticity of TAMs makes them an attractive target for anticancer therapies and more research should be conducted to explore this potential therapeutic strategy.